The Zimbabwean government has introduced a breakthrough approach for HIV prevention, known as injectable cabotegravir (CAB_LA), which is currently accessible for pre-exposure prophylaxis (PrEP).
This represents a huge advancement in HIV prevention efforts. This scientific discovery provides a practical and effective way to prevent HIV from spreading among high-risk persons.
This injection only needs to be given once every two months, in contrast to the traditional daily pill regimen for PrEP. This novel strategy offers those looking for virus prevention a more practical and controllable choice.
Respected physician Dr. Misheck Ruwende expressed his excitement by saying, “Exciting news! Today was the first injection of HIV prophylaxis given in Zimbabwe. This is a huge step forward, providing a more practical substitute for daily PrEP medications. The injection, given once each every two months, heralds a new era in HIV prevention.
ALSO READ: Brothers Arrested For Assaulting Two Police Officers
In another story, Zimbabwe Receives 2,000 Doses of Cutting-Edge PrEP for HIV.In a significant stride towards enhancing HIV prevention strategies, Population Solutions for Health recently marked a milestone as the first recipient of care for the revolutionary injectable cabotegravir (CAB_LA) at Harare’s New Start Centre.
This groundbreaking biomedical prevention method, now available as pre-exposure prophylaxis (PrEP), is poised to transform the landscape of HIV transmission prevention among high-risk populations.
Injectable PrEP has emerged as a beacon of hope in the global endeavor to eliminate HIV/AIDS as a public health threat by 2030. Zimbabwe, standing at the forefront of progressive healthcare initiatives, has become the third African nation to introduce injectable cabotegravir (CAB-LA) following Malawi and Zambia…read in full